David M Heyer MD

Hematologic Oncology

Division Chief, Hematology/Oncology Inova Schar Cancer Institute

3300 Gallows RdFalls Church, VA 22042
Phone+1 571-472-2474
Fax+1 571-472-0241

Dr. Heyer is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Heyer's full profile Already have an account?

Summary

David Heyer, MD, is an experienced oncologist based in Fairfax, VA. He specializes in Hematologic Oncology and holds several subspecialties in fields such as hematologic oncology, myeloproliferative disorders, lymphoma, myelodysplastic syndromes , and leukemia. His education spans the University of California in San Francisco where he did his fellowship and residency, and the University of Michigan Medical School where he graduated in 1985. Dr. Heyer has numerous publications under his name with his most recent works focusing on cancer care during the COVID pandemic. He has received several awards including the Meaningful Use Stage 1 Certification from Centers for Medicare & Medicaid Services and several recognitions from Castle Connolly, including Top Doctors in the Washington DC and Baltimore areas and Northern Virginia Magazine.

Education & Training

University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1989 - 1991
University of California (San Francisco)Residency, Internal Medicine, 1985 - 1989
University of Michigan Medical SchoolClass of 1985

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1987 - Present
VA State Medical License 1991 - 2028
CO State Medical License 2025 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2012, 2014, 2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2017
CMS Meaningful Use Stage 1 Certification Allscripts FollowMyHealth, Allscripts, 2012, 2014, 2017

Publications & Presentations

PubMed

8 citations
Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study.
Mary Steimer, Jessica Leabo, Hongkun Wang, David Heyer, Nancy Addison
JCO Oncology Practice. 2021-04-01
Risk of COVID-19 in Patients With Cancer.
Michael L. Maitland, David Heyer, Mardi Gomberg-Maitland
JAMA Oncology. 2020-09-01
25 citations
Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently in...
Rui R. He, Zacharia Nayer, Matthew C. Hogan, Raymund S. Cuevo, Kimberly Woodward
Case Reports in Hematology. 2019-12-07